Melanoma, resistant chronic myelocytic leukemia; Recurrent, metastatic, or inoperable carcinoma of the ovary; Hydroxyurea used concomitantly with irradiation therapy is intended for use in the local control of primary squamous cell (epidermoid) carcinomas of the head and neck, excluding the lip.